Home › Funds › Cormorant Asset Management, LP › PHVS
Cormorant Asset Management, LP position in PHVS
PHARVARIS N V · Health Care
Cormorant Asset Management, LP reported holding 750,000 shares of PHVS (PHARVARIS N V) in its Q2 2026 13F filing — a position valued at US$25.9M, representing 1.33% of its reported portfolio and ranking #24 among its reported holdings. Cormorant Asset Management, LP has disclosed PHVS holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Cormorant Asset Management, LP's PHVS position evolved
Cormorant Asset Management, LP first disclosed a stake in PHVS in Q3 2023 at 1,361,460 shares (US$28.4M). The position peaked in Q4 2023 at 1,711,460 shares, worth US$48.0M. Across 12 filings, Cormorant Asset Management, LP increased the stake 1 time(s), trimmed it 6 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 750,000 shares valued at US$25.9M — a reduction of -250,000 shares quarter over quarter.. Notable position changes include a 26% increase in Q4 2023 (shares fell 33% over the following quarter), a 25% trim in Q2 2026 (shares fell 8% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.36M | $28.41M | New |
| Q4 2023 | 1.71M | $48.01M | Add |
| Q1 2024 | 1.71M | $39.55M | Hold |
| Q2 2024 | 1.47M | $27.57M | Reduce |
| Q3 2024 | 1.47M | $27.16M | Hold |
| Q4 2024 | 1.47M | $28.11M | Hold |
| Q1 2025 | 1.47M | $23.02M | Hold |
| Q2 2025 | 1.45M | $25.60M | Reduce |
| Q3 2025 | 1.36M | $34.01M | Reduce |
| Q4 2025 | 1.08M | $30.05M | Reduce |
| Q1 2026 | 1.00M | $28.25M | Reduce |
| Q2 2026 | 750.00K | $25.93M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PHVS and 13F data
PHVS (PHARVARIS N V) is a Health Care company. 49 other funds we track also report a position in PHVS — the largest reported positions include GENERAL ATLANTIC, L.P. (US$226.5M), Foresite Capital Management IV, LLC (US$165.2M), venBio Partners LLC (US$160.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PHVS
- GENERAL ATLANTIC, L.P. 6.55M sh · $226.53M · Q2 2026
- Foresite Capital Management IV, LLC 4.78M sh · $165.24M · Q2 2026
- venBio Partners LLC 4.64M sh · $160.57M · Q2 2026
- EQT Fund Management S.a r.l. 3.42M sh · $118.42M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 3.38M sh · $116.74M · Q2 2026
- Bain Capital Life Sciences Investors, LLC 2.68M sh · $92.52M · Q2 2026
- Commodore Capital LP 1.43M sh · $49.28M · Q2 2026
- Novo Holdings A/S 1.40M sh · $48.41M · Q2 2026
- Saturn V Capital Management LP 1.31M sh · $45.44M · Q2 2026
- TCG Crossover Management, LLC 1.01M sh · $34.86M · Q2 2026
- Sofinnova Investments, Inc. 881.30K sh · $30.48M · Q2 2026
- 5AM Venture Management, LLC 797.60K sh · $27.58M · Q2 2026
More on Cormorant Asset Management, LP
FAQ
How long has Cormorant Asset Management, LP held PHVS?
Cormorant Asset Management, LP has disclosed PHVS holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Cormorant Asset Management, LP's current position in PHVS?
As of Q2 2026, Cormorant Asset Management, LP holds 750.00K shares of PHVS (PHARVARIS N V), valued at $25.93M, representing 1.33% of its reported portfolio and ranking #24.
Has Cormorant Asset Management, LP been buying or selling PHVS?
In the latest 13F filing (Q2 2026), Cormorant Asset Management, LP reduced its position in PHVS. The position peaked in Q4 2023 at 1.71M shares.
Which other funds hold PHVS?
Other major institutional holders of PHVS include GENERAL ATLANTIC, L.P., Foresite Capital Management IV, LLC, venBio Partners LLC, among 49 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.